B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Active Not Recruiting Phase 2 Trials for Sapanisertib (DB11836)

IndicationStatusPhase
DBCOND0081965 (B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02484430Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic LeukemiaTreatment